Structural features of target RNA molecules greatly modulate the cleavage efficiency of trans-acting delta ribozymes

Biochemistry

Volumn 46, Issue 18, 2007, Pages 5523-5533

  Świa̧tkowska, Agata ^a   Dutkiewicz, Mariola ^a   Ciesiołka, Jerzy ^a  

^a INSTITUTE OF BIOORGANIC CHEMISTRY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ENZYMES; OLIGONUCLEOTIDES; RNA;

REACTION TRAJECTORY; RIBOZYMES;

MOLECULAR STRUCTURE;

RIBOZYME;

ARTICLE; DNA LIBRARY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA CLEAVAGE; RNA STRUCTURE;

BASE SEQUENCE; CATALYSIS; COMBINATORIAL CHEMISTRY TECHNIQUES; HEPATITIS DELTA VIRUS; HUMANS; KINETICS; MOLECULAR SEQUENCE DATA; RNA, CATALYTIC; RNA, VIRAL; SUBSTRATE SPECIFICITY; TRANS-ACTIVATORS;

HEPATITIS C VIRUS;

EID: 34248157282     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi6024287     Document Type: Article

References (47)

1. Shih, I. H., and Been, M. D. (2002) Catalytic strategies of the hepatitis delta virus ribozymes, Annu. Rev. Biochem. 71, 887-917.
2. Wadkins, T. S., and Been, M. D. (2002) Ribozyme activity in the genomic and antigenomic RNA strands of hepatitis delta virus, Cell. Mol. Life Sci. 59, 112-125.
3. Bergeron, L. J., Ouellet, J., and Perreault, J. P. (2003) Ribozyme-based gene-inactivation systems require a fine comprehension of their substrate specificities; the case of delta ribozyme, Curr. Med. Chem. 10, 2589-2597.
4. Levesque, D., Choufani, S., and Perreault, J. P. (2002) Delta ribozyme benefits from a good stability in vitro that becomes outstanding in vivo, RNA 8, 464-477.
5. Roy, G., Ananvoranich, S., and Perreault, J. P. (1999) Delta ribozyme has the ability to cleave in trans an mRNA, Nucleic Acids Res. 15, 942-948.
6. Bergeron, L. J., and Perreault, J. P. (2002) Development and comparison of procedures for the selection of delta ribozyme cleavage sites within the hepatitis B virus, Nucleic Acids Res. 1, 4682-4691.
7. D'Anjou, F., Bergeron, L. J., Larbi, N. B., Fournier, I., Salzet, M., Perreault, J. P., and Day, R. (2004) Silencing of SPC2 expression using an engineered delta ribozyme in the mouse βTC-3 endocrine cell line, J. Biol. Chem. 2, 14232-14239.
8. Al-Anouti, F., and Ananvoranich, S. (2002) Comparative analysis of antisense RNA, double-stranded RNA, and delta ribozyme-mediated gene regulation in Toxoplasma gondii, Antisense Nucleic Acid Drug Dev. 12, 275-281.
9. Sheng, J., Al-Anouti, F., and Ananvoranich, S. (2004) Engineered delta ribozymes can simultaneously knock down the expression of the genes encoding uracil phosphoribosyltransferase and hypoxanthine-xanthine-guanine phosphoribosyltransferase in Toxoplasma gondii, Int. J. Parasitol. 9, 253-263.
10. Kato, Y., Kuwabara, T., Warashina, M., Toda, H., and Taira, K. (2001) Relationships between the activities in vitro and in vivo of various kinds of ribozyme and their intracellular localization in mammalian cells, J. Biol. Chem. 276, 15378-15385.
11. Fiola, K., Perreault, J. P., and Cousineau, B. (2006) Gene targeting in the gram-positive bacterium Lactococcus lactis, using various delta ribozymes, Appl. Environ. Microbiol. 72, 869-879.
12. Yu, Y. C., Mao, Q., Gu, C. H., Li, Q. F., and Wang, Y. M. (2002) Activity of HDV ribozymes to frans-cleave HCV RNA, World J. Gastroenterol. 8, 694-698.
13. Schurer, H., Lang, K., Schuster, J., and Mori, M. (2002) A universal method to produce in vitro transcripts with homogeneous 3′ ends, Nucleic Acids Res. 30, e56.
14. Wichlacz, A., Łȩgiewicz, M., and Ciesiołka, J. (2004) Generating in vitro transcripts with homogenous 3′ ends using trans-acting antigenomic delta ribozyme, Nucleic Acids Res. 32, e39.
15. Cullen, B. R. (2006) Enhancing and confirming the specificity of RNAi experiments, Nat. Methods 3, 677-681.
16. Rossi, J. J. (2006) RNAi as a treatment for HIV-1 infection, BioTechniques Suppl., 25-29.
17. Gitlin, L., Karelsky, S., and Andino, R. (2002) Short interfering RNA confers intracellular antiviral immunity in human cells, Nature 418, 430-434.
18. Boden, D., Pusch, O., Lee, F., Tucker, L., and Ramratnam, B. (2003) Human immunodeficiency virus type 1 escape from RNA interference, J. Virol. 77, 11531-11535.
19. Yokota, T., Sakamoto, N., Enomoto, N., Tanabe, Y., Miyagishi, M., Maekawa, S., Yi, L., Kurosaki, M., Taira, K., Watanabe, M., and Mizusawa, H. (2003) Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs, EMBO Rep. 4, 602-608.
20. Wilson, J. A., and Richardson, C. D. (2006) Future promise of siRNA and other nucleic acid based therapeutics for the treatment of chronic HCV, Infect. Disord. Drug Targets 6, 43-56.
21. Dutkiewicz, M., and Ciesiolka, J. (2005) Structural characterization of the highly conserved 98-base sequence at the 3′ end of HCV RNA genome and the complementary sequence located at the 5′ end of the replicative viral strand, Nucleic Acids Res. 33, 693-703.
22. Wrzesiński, J., Łȩgiewicz, M., Smólska, B., and Ciesiołka, J. (2001) Catalytic cleavage of cis- and trans-acting antigenomic delta ribozymes in the presence of various divalent metal ions, Nucleic Acids Res. 29, 4482-4492.
23. Nishikawa, F., Roy, M., Fauzi, H., and Nishikawa, S. (1999) Detailed analysis of stem I and its 5′ and 3′ neighbor regions in the trans-acting HDV ribozyme, Nucleic Acids Res. 27, 403-410.
24. Ananvoranich, S., Lafontaine, D. A., and Perreault, J. P. (1999) Mutational analysis of the antigenomic trans-acting delta ribozyme: the alterations of the middle nucleotides located on the P1 stem, Nucleic Acids Res. 27, 1473-1479.
25. Wrzesiński, J., Łȩgiewicz, M., and Ciesiołka, J. (2000) Mapping of accessible sites for oligonucleotide hybridization on hepatitis delta virus ribozymes, Nucleic Acids Res. 28, 1785-1793.
26. Nishikawa, F., Fauzi, H., and Nishikawa, S. (1997) Detailed analysis of base preferences at the cleavage site of a trans-acting HDV ribozyme: a mutation that changes cleavage site specificity, Nucleic Acids Res. 25, 1605-1610.
27. Mathews, D. H. (2005) Predicting a set of minimal free energy RNA secondary structures common to two sequences, Bioinformatics 21, 2246-2253.
28. Matveeva, O. V., Mathews, D. H., Tsodikov, A. D., Shabalina, S. A., Gesteland, R. F., Atkins, J. F., and Freier, S. M. (2003) Thermodynamic criteria for high hit rate antisense oligonucleotide design, Nucleic Acids Res. 31, 4989-4994.
29. +2-induced cleavage of RNA, in Handbook of RNA Biochemistry (Westhof, E., Bindereif, A., Schon, A., and Hartmann, R. K., Eds.) pp 214-228, Wiley-VCH Verlag, Weinheim, Germany.
30. Shih, I., and Been, M. D. (2001) Energetic contribution of non-essential 5′ sequence to catalysis in a hepatitis delta virus ribozyme, EMBO J. 20, 4884-4891.
31. Campbell, T. B., and Cech, T. R. (1995) Identification of ribozymes within a ribozyme library that efficiently cleave a long substrate RNA, RNA 1, 598-609.
32. Lieber, A., and Strauss, M. (1995) Selection of efficient cleavage sites in target RNAs by using a ribozyme expression library, Mol. Cell. Biol. 15, 540-551.
33. Yu, Q., Pecchia, D. B., Kingsley, S. L., Heckman, J. E., and Burke, J. M. (1998) Cleavage of highly structured viral RNA molecules by combinatorial libraries of hairpin ribozymes, J. Biol. Chem. 273, 23524-23533.
34. Smith, R. M., Walton, C. M., Wu, C. H., and Wu, G. Y. (2002) Secondary structure and hybridization accessibility of hepatitis C virus 3′-terminal sequences, J. Virol. 76, 9563-9574.
35. Mir, K. U., and Southern, E. M. (1999) Determining the influence of structure on hybridization using oligonucleotide arrays, Nat. Biotechnol. 17, 788-792.
36. Deschenes, P., Lafontaine, D. A., Charland, S., and Perreault, J. P. (2000) Nucleotides -1 to -4 of hepatitis delta ribozyme substrate increase the specificity of ribozyme cleavage, Antisense Nucleic Acid Drug Dev. 10, 53-61.
37. Ke, A., Zhou, K., Ding, F., Cate, J. H., and Doudna, J. A. (2004) A conformational switch controls hepatitis delta virus ribozyme catalysis, Nature 429, 201-205.
38. Mercure, S., Lafontaine, D. A., Ananvoranich, S., and Perreault, J. P. (1998) Kinetic analysis of delta ribozyme cleavage, Biochemistry 37, 16975-16982.
39. Shih, I., and Been, M. D. (2000) Kinetic scheme for intermolecular RNA cleavage by a ribozyme derived from hepatitis delta virus RNA, Biochemistry 39, 9055-9066.
40. Pereira, M. J., Harris, D. A., Rueda, D., and Walter, N. G. (2002) Reaction pathway of the trans-acting hepatitis delta virus ribozyme: A conformational change accompanies catalysis, Biochemistry 41, 730-740.
41. Harris, D. A., Rueda, D., and Walter, N. G. (2002) Local conformational changes in the trans-acting hepatitis delta virus ribozyme accompany catalysis, Biochemistry 41, 12051-12061.
42. 2+ is accompanied by a conformational change, Genes Cells 7, 567-579.
43. Harris, D. A., Tinsley, R. A., and Walter, N. G. (2004) Terbium-mediated footprinting probes a catalytic conformational switch in the antigenomic hepatitis delta virus ribozyme, J. Mol. Biol. 341, 389-403.
44. Gondert, M. E., Tinsley, R. A., Rueda, D., and Walter, N. G. (2006) Catalytic core structure of the trans-acting HDV ribozyme is subtly influenced by sequence variation outside the core, Biochemistry 45, 7563-7573.
45. Cairns, M. J., Hopkins, T. M., Witherington, C., Wang, L., and Sun, L. Q. (1999) Target site selection for an RNA-cleaving catalytic DNA, Nat. Biotechnol. 17, 480-486.
46. Dunham, C. M., Murray, J. B., and Scott, W. G. (2003) A helical twist-induced conformational switch activates cleavage in the hammerhead ribozyme, J. Mol. Biol. 332, 327-336.
47. Zhuang, X., Kim, H., Pereira, M. J., Babcock, H. P., Walter, N. G., and Chu, S. (2002) Correlating structural dynamics and function in single ribozyme molecules, Science 296, 1473-1476.